Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 44 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01DK106540, R01DK106540, P30 CA022453 , R21GM140352, T32-CA009531
NIDDK NIH HHS
Grant: R01 DK124612
NIDDK NIH HHS
Grant: R01 DK106540
NCI NIH HHS
Grant: P30 CA022453
NCI NIH HHS
Grant: T32 CA009531
NIGMS NIH HHS
Grant: R21 GM140352
National Institutes of Health
Grant: 5R01DK106540-02
Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease
National Institutes of Health
Grant: 3P30CA022453-37S2
Cancer Center Support Grant
National Institutes of Health
Grant: 2T32CA009531-21
Training Program in the Biology of Cancer
National Institutes of Health
Grant: 5R01DK124612-03
A Precision Targeted Therapeutics for Nonalcoholic Fatty Liver Disease
National Institutes of Health
Grant: 1R21GM140352-01
MS-based metabolite identification
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche
Additional file 1 of Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche